Basel Medical Group Ltd Ordinary Shares (BMGL) Stock
Basel Medical Group Ltd, an entity established in Singapore in 2023, is dedicated to delivering a comprehensive range of healthcare services. Its operations span multiple key areas, including specialist medical expertise, medical supplies and equipment, advanced medical technology solutions, and pharmaceutical products.
Valuation
Financials & Margins
Annual Financials (USD)
Balance Sheet (USD)
Latest News
Cash Flow (USD)
Valuation & Return Ratios
Ownership
Peer Comparison
About Basel Medical Group Ltd Ordinary Shares
Basel Medical Group Ltd, an entity established in Singapore in 2023, is dedicated to delivering a comprehensive range of healthcare services. Its operations span multiple key areas, including specialist medical expertise, medical supplies and equipment, advanced medical technology solutions, and pharmaceutical products.
Basel Medical Group Ltd Ordinary Shares is led by CEO Yen Feng Chhoa, employs 32 people, headquartered in SG, publicly traded since 2025.
Basel Medical Group Ltd Ordinary Shares (BMGL) stock trades at $5.70 with a market capitalization of $8.92M. The stock is valued at a price-to-earnings (P/E) ratio of -20.84, price-to-book of 1.82, price-to-sales of 0.80. Over the past 52 weeks the stock has ranged between $4.60 and $26.40, and currently trades 78.4% below its 52-week high.
On profitability, Basel Medical Group Ltd Ordinary Shares generates a return on equity (ROE) of -173.64%, return on capital employed of -35.92%, an operating margin of -31.66%, a net profit margin of -67.66%.
Official website: baselmedical.com